205 related articles for article (PubMed ID: 29649779)
1. Activation of Hepatic Stellate Cells During Liver Carcinogenesis Requires Fibrinogen/Integrin αvβ5 in Zebrafish.
Yan C; Yang Q; Gong Z
Neoplasia; 2018 May; 20(5):533-542. PubMed ID: 29649779
[TBL] [Abstract][Full Text] [Related]
2. Interaction of hepatic stellate cells with neutrophils and macrophages in the liver following oncogenic kras activation in transgenic zebrafish.
Yang Q; Yan C; Gong Z
Sci Rep; 2018 May; 8(1):8495. PubMed ID: 29855567
[TBL] [Abstract][Full Text] [Related]
3. Paracrine activation of hepatic stellate cells in platelet-derived growth factor C transgenic mice: evidence for stromal induction of hepatocellular carcinoma.
Wright JH; Johnson MM; Shimizu-Albergine M; Bauer RL; Hayes BJ; Surapisitchat J; Hudkins KL; Riehle KJ; Johnson SC; Yeh MM; Bammler TK; Beyer RP; Gilbertson DG; Alpers CE; Fausto N; Campbell JS
Int J Cancer; 2014 Feb; 134(4):778-88. PubMed ID: 23929039
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Associated Neutrophils and Macrophages Promote Gender Disparity in Hepatocellular Carcinoma in Zebrafish.
Yan C; Yang Q; Gong Z
Cancer Res; 2017 Mar; 77(6):1395-1407. PubMed ID: 28202512
[TBL] [Abstract][Full Text] [Related]
6. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
[TBL] [Abstract][Full Text] [Related]
7. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
[TBL] [Abstract][Full Text] [Related]
8. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
Carloni V; Luong TV; Rombouts K
Liver Int; 2014 Jul; 34(6):834-43. PubMed ID: 24397349
[TBL] [Abstract][Full Text] [Related]
9. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis.
Filliol A; Saito Y; Nair A; Dapito DH; Yu LX; Ravichandra A; Bhattacharjee S; Affo S; Fujiwara N; Su H; Sun Q; Savage TM; Wilson-Kanamori JR; Caviglia JM; Chin L; Chen D; Wang X; Caruso S; Kang JK; Amin AD; Wallace S; Dobie R; Yin D; Rodriguez-Fiallos OM; Yin C; Mehal A; Izar B; Friedman RA; Wells RG; Pajvani UB; Hoshida Y; Remotti HE; Arpaia N; Zucman-Rossi J; Karin M; Henderson NC; Tabas I; Schwabe RF
Nature; 2022 Oct; 610(7931):356-365. PubMed ID: 36198802
[TBL] [Abstract][Full Text] [Related]
10. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
[TBL] [Abstract][Full Text] [Related]
11. Paracrine effects of CCN3 from non-cancerous hepatic cells increase signaling and progression of hepatocellular carcinoma.
Li W; Liao X; Ning P; Cao Y; Zhang M; Bu Y; Lv J; Jia Q
BMC Cancer; 2019 Apr; 19(1):395. PubMed ID: 31029128
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
[TBL] [Abstract][Full Text] [Related]
13. FOXS1 is increased in liver fibrosis and regulates TGFβ responsiveness and proliferation pathways in human hepatic stellate cells.
Bates EA; Kipp ZA; Lee WH; Martinez GJ; Weaver L; Becker KN; Pauss SN; Creeden JF; Anspach GB; Helsley RN; Xu M; Bruno MEC; Starr ME; Hinds TD
J Biol Chem; 2024 Mar; 300(3):105691. PubMed ID: 38280429
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
Matsuda M; Seki E
Semin Liver Dis; 2020 Aug; 40(3):307-320. PubMed ID: 32242330
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1.
Yang L; Inokuchi S; Roh YS; Song J; Loomba R; Park EJ; Seki E
Gastroenterology; 2013 May; 144(5):1042-1054.e4. PubMed ID: 23391818
[TBL] [Abstract][Full Text] [Related]
16. Periostin involved in the activated hepatic stellate cells-induced progression of residual hepatocellular carcinoma after sublethal heat treatment: its role and potential for therapeutic inhibition.
Zhang R; Lin XH; Ma M; Chen J; Chen J; Gao DM; Cui JF; Chen RX
J Transl Med; 2018 Nov; 16(1):302. PubMed ID: 30400797
[TBL] [Abstract][Full Text] [Related]
17. p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer.
Duran A; Hernandez ED; Reina-Campos M; Castilla EA; Subramaniam S; Raghunandan S; Roberts LR; Kisseleva T; Karin M; Diaz-Meco MT; Moscat J
Cancer Cell; 2016 Oct; 30(4):595-609. PubMed ID: 27728806
[TBL] [Abstract][Full Text] [Related]
18. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.
Farid RM; Abu-Zeid RM; El-Tawil A
Int J Clin Exp Pathol; 2014; 7(5):2707-17. PubMed ID: 24966992
[TBL] [Abstract][Full Text] [Related]
20.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
